1. Home
  2. SLI vs SGP Comparison

SLI vs SGP Comparison

Compare SLI & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standard Lithium Ltd.

SLI

Standard Lithium Ltd.

HOLD

Current Price

$4.00

Market Cap

906.4M

Sector

Industrials

ML Signal

HOLD

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$19.17

Market Cap

932.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLI
SGP
Founded
1998
2019
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.4M
932.9M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
SLI
SGP
Price
$4.00
$19.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$5.25
$45.00
AVG Volume (30 Days)
1.7M
50.1K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.49
$19.46
52 Week High
$6.40
$30.56

Technical Indicators

Market Signals
Indicator
SLI
SGP
Relative Strength Index (RSI) 55.71 29.82
Support Level $3.97 N/A
Resistance Level $4.08 $26.29
Average True Range (ATR) 0.23 1.59
MACD 0.01 -0.38
Stochastic Oscillator 53.37 2.61

Price Performance

Historical Comparison
SLI
SGP

About SLI Standard Lithium Ltd.

Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company the company's flagship projects are located in the Smackover Formation, a world-class lithium brine asset, focused in Arkansas and Texas. It is also Standard Lithium is advancing the South West Arkansas project, a greenfield project located in southern Arkansas, and strengthening lithium brine prospects in East Texas. Its other project comprises the Lanxess Property Project; and California Properties. The technologies used for the projects are : Direct Lithium Extraction; Demonstration Plant; SiFT; Lithium Sulfide; and Aqualung.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: